Literature DB >> 20681595

Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.

Ronak Y Patel1, Robert J Doerksen.   

Abstract

Structure-based drug design of protein-kinase inhibitors has been facilitated by availability of an enormous number of structures in the Protein Databank (PDB), systematic analyses of which can provide insight into the factors that govern ligand-protein kinase interactions and into the conformational variability of the protein kinases. In this study, a nonredundant database containing 755 unique, curated, and annotated PDB protein kinase-inhibitor complexes (each consisting of a single protein kinase chain, a ligand, and water molecules around the ligand) was created. With this dataset, analyses were performed of protein conformational variability and interactions of ligands with 11 P-loop residues. Analysis of ligand-protein interactions included ligand atom preference, ligand-protein hydrogen bonds, and the number and position of crystallographic water molecules around important P-loop residues. Analysis of variability in the conformation of the P-loop considered backbone and side-chain dihedral angles, and solvent accessible surface area (SASA). A distorted conformation of the P-loop was observed for some of the protein kinase structures. Lower SASA was observed for the hydrophobic residue in beta1 of several members of the AGC family of protein kinases. Our systematic studies were performed amino acid-by-amino acid, which is unusual for analyses of protein kinase-inhibitor complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20681595      PMCID: PMC3235399          DOI: 10.1021/pr100662s

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  56 in total

1.  Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

Authors:  M Mohammadi; G McMahon; L Sun; C Tang; P Hirth; B K Yeh; S R Hubbard; J Schlessinger
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

Review 2.  Protein kinase inhibitors: structural insights into selectivity.

Authors:  Ram Thaimattam; Rahul Banerjee; Rajni Miglani; Javed Iqbal
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil.

Authors:  Hiroto Yamaguchi; Miyuki Kasa; Mutsuki Amano; Kozo Kaibuchi; Toshio Hakoshima
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

4.  Functional classification of protein kinase binding sites using Cavbase.

Authors:  Daniel Kuhn; Nils Weskamp; Eyke Hüllermeier; Gerhard Klebe
Journal:  ChemMedChem       Date:  2007-10       Impact factor: 3.466

Review 5.  Profile hidden Markov models.

Authors:  S R Eddy
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

6.  RASMOL: biomolecular graphics for all.

Authors:  R A Sayle; E J Milner-White
Journal:  Trends Biochem Sci       Date:  1995-09       Impact factor: 13.807

7.  Rational design of inhibitors that bind to inactive kinase conformations.

Authors:  Yi Liu; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2006-07       Impact factor: 15.040

8.  Mechanism of CDK5/p25 binding by CDK inhibitors.

Authors:  Marina Mapelli; Lucia Massimiliano; Claudia Crovace; Markus A Seeliger; Li-Huei Tsai; Laurent Meijer; Andrea Musacchio
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

9.  Conservation, variability and the modeling of active protein kinases.

Authors:  James D R Knight; Bin Qian; David Baker; Rashmi Kothary
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

10.  Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

Authors:  Y Gu; J Rosenblatt; D O Morgan
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  15 in total

1.  Development of a highly selective c-Src kinase inhibitor.

Authors:  Kristoffer R Brandvold; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2012-06-04       Impact factor: 5.100

Review 2.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

3.  Computational analysis of kinase inhibitor selectivity using structural knowledge.

Authors:  Yu-Chen Lo; Tianyun Liu; Kari M Morrissey; Satoko Kakiuchi-Kiyota; Adam R Johnson; Fabio Broccatelli; Yu Zhong; Amita Joshi; Russ B Altman
Journal:  Bioinformatics       Date:  2019-01-15       Impact factor: 6.937

4.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

5.  Electrophilic fragment-based design of reversible covalent kinase inhibitors.

Authors:  Rand M Miller; Ville O Paavilainen; Shyam Krishnan; Iana M Serafimova; Jack Taunton
Journal:  J Am Chem Soc       Date:  2013-03-29       Impact factor: 15.419

6.  Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.

Authors:  Zheng Zhao; Qingsong Liu; Spencer Bliven; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2017-04-04       Impact factor: 7.446

7.  Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge.

Authors:  Zhaofeng Ye; Matthew P Baumgartner; Bentley M Wingert; Carlos J Camacho
Journal:  J Comput Aided Mol Des       Date:  2016-08-29       Impact factor: 3.686

8.  Docking challenge: protein sampling and molecular docking performance.

Authors:  Khaled M Elokely; Robert J Doerksen
Journal:  J Chem Inf Model       Date:  2013-04-15       Impact factor: 4.956

9.  Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine.

Authors:  Frank E Kwarcinski; Christel C Fox; Michael E Steffey; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2012-09-05       Impact factor: 5.100

10.  Computational study of Gleevec and G6G reveals molecular determinants of kinase inhibitor selectivity.

Authors:  Yen-Lin Lin; Yilin Meng; Lei Huang; Benoît Roux
Journal:  J Am Chem Soc       Date:  2014-10-07       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.